Rat cytochromes P450 (CYP) specifically contribute to the reductive bioactivation of AQ4N, an alkylaminoanthraquinone-di-N-oxide anticancer prodrug

Author: Raleigh S. M.   Wanogho E.   Burke M. D.   Patterson L. H.  

Publisher: Informa Healthcare

ISSN: 1366-5928

Source: Xenobiotica, Vol.29, Iss.11, 1999-11, pp. : 1115-1122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content